Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
943,886
-
Share change
-
+34,682
-
Total reported value
-
$153,156,854
-
Price per share
-
$162.09
-
Number of holders
-
111
-
Value change
-
+$5,721,262
-
Number of buys
-
34
-
Number of sells
-
44
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q1 2023
As of 31 Mar 2023,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
943,886 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, Miller Investment Management, LP, MORGAN STANLEY, JPMORGAN CHASE & CO, LPL Financial LLC, BANK OF AMERICA CORP /DE/, MOGY JOEL R INVESTMENT COUNSEL INC, Royal Bank of Canada, UBS Group AG, and Consolidated Investment Group LLC.
This page lists
113
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.